TIAF1 Antikörper (AA 1-115)
-
- Target Alle TIAF1 Antikörper anzeigen
- TIAF1 (TGFB1-Induced Anti-Apoptotic Factor 1 (TIAF1))
-
Bindungsspezifität
- AA 1-115
-
Reaktivität
- Human
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser TIAF1 Antikörper ist unkonjugiert
-
Applikation
- ELISA, Immunohistochemistry (IHC)
- Kreuzreaktivität
- Human
- Aufreinigung
- Antigen Affinity Purified
- Immunogen
- Recombinant Human TGFB1-induced anti-apoptotic factor 1 protein (1-115AA)
- Isotyp
- IgG
- Top Product
- Discover our top product TIAF1 Primärantikörper
-
-
- Applikationshinweise
- Recommended dilution: IHC:1:20-1:200,
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Buffer
- PBS with 0.02 % sodium azide, 50 % glycerol, pH 7.3.
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- -20 °C,-80 °C
- Informationen zur Lagerung
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
- Target
- TIAF1 (TGFB1-Induced Anti-Apoptotic Factor 1 (TIAF1))
- Andere Bezeichnung
- TIAF1 (TIAF1 Produkte)
- Synonyme
- myo18l1 antikoerper, tiaf1 antikoerper, wu:fb52c07 antikoerper, MAJN antikoerper, SPR210 antikoerper, myosin XVIIIAb antikoerper, TGFB1-induced anti-apoptotic factor 1 antikoerper, myo18ab antikoerper, TIAF1 antikoerper
- Hintergrund
-
Background: Inhibits the cytotoxic effects of TNF-alpha and overexpressed TNF receptor adapters TRADD, FADD, and RIPK1. Involved in TGF-beta1 inhibition of IkappaB-alpha expression and suppression of TNF-mediated IkappaB-alpha degradation.
Aliases: TIAF1 antibody, TGFB1-induced anti-apoptotic factor 1 antibody, 12 kDa TGF-beta-1-induced antiapoptotic factor antibody
- UniProt
- O95411
-